{"id":971424,"date":"2026-06-11T13:36:09","date_gmt":"2026-06-11T17:36:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/"},"modified":"2026-06-11T13:36:09","modified_gmt":"2026-06-11T17:36:09","slug":"adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/","title":{"rendered":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwalignl { text-align: left }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law<\/b><\/p>\n<p>\nA securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws.<\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nLeading securities law firm <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=Bleichmar+Fonti+%26amp%3B+Auld+LLP&amp;index=1&amp;md5=95019b07e8a7a190ef52686fbd7c1547\"><b>Bleichmar Fonti &amp; Auld LLP<\/b><\/a> announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company\u2019s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.<\/p>\n<p>\nIf you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=2&amp;md5=95fcd771869ed5b8a094c65a9156ba39\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a>.<\/p>\n<p><b>Key Details of the ADMA ($ADMA) Class Action:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Lead Plaintiff Deadline: <\/b>August 10, 2026\n<\/li>\n<li><b>Alleged Misconduct: <\/b>Securities fraud relating to allegations that ADMA\u2019s reported 20% growth for 2025 was driven by a channel stuffing scheme\n<\/li>\n<li><b>Largest Stock Drop: <\/b>March 24, 2026 \u2013 16.6% Stock Drop\n<\/li>\n<li><b>Court: <\/b>U.S. District Court for the District of New Jersey\n<\/li>\n<li><b>Action: <\/b>Contact <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=BFA+Law&amp;index=3&amp;md5=29e275a9340c82ef08548f7b6caacaf5\">BFA Law<\/a> to discuss your rights\n<\/li>\n<\/ul>\n<p>\nInvestors have until August 10, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ADMA securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned <i>Mazzarino v. ADMA Biologics, Inc., et al.<\/i>, No. 26-cv-6918.<\/p>\n<p><b>Why is ADMA Biologics Being Sued for Securities Fraud?<\/b><\/p>\n<p>\nADMA has been sued for securities fraud following significant stock drops resulting from potential violations of the federal securities laws. The decline in AMDA\u2019s stock price caused significant losses to investors.<\/p>\n<p>\nADMA is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing specialty biologics. ADMA\u2019s flagship product is ASCENIV, a liquid immune globulin solution used to treat Primary Humoral Immunodeficiency in adults and adolescents.<\/p>\n<p>\nDuring the relevant period, as alleged, ADMA was engaged in a de facto channel stuffing scheme to drive revenue growth in the face of waning demand for its flagship product, ASCENIV, and failed to disclose related party transactions.<\/p>\n<p><b>Why did ADMA Biologics\u2019 Stock Drop?<\/b><\/p>\n<p>\nOn March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and \u20133% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA to book revenue and \u201creport[] growth that was never there.\u201d According to Culper Research, had ADMA not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.<\/p>\n<p>\nThis news caused the price of ADMA stock to decline $2.26 per share, or 16.6%, from a closing price of $13.59 per share on March 23, 2026, to $11.33 per share on March 24, 2026. ADMA\u2019s stock declined a further $1.70 per share, or 15%, the following day, to close at $9.63 per share on March 25, 2026.<\/p>\n<p>\nThen, on March 26, 2026, Investing.com published an article titled \u201cCantor downgrades ADMA Biologics stock rating on short report concerns.\u201d This news caused the price of ADMA stock to decline $1.34 per share, or 13.9%, from a closing price of $9.63 per share on March 25, 2026, to $8.29 per share on March 29, 2026.<\/p>\n<p><b>Click here for more information:<\/b><b><span class=\"bwuline\" \/><\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=4&amp;md5=9409d44612bf9d63773fcc5e823970b1\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><b>.<\/b><\/p>\n<p><b>What Can You Do?<\/b><\/p>\n<p>\nIf you invested in ADMA Biologics, you may have legal options and are encouraged to submit your information to the firm.<\/p>\n<p>\nAll representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n<p><b>Submit your information by visiting:<\/b><\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=5&amp;md5=178579788775ff5be1423f5edfe760d6\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><\/p>\n<p>\nOr contact:<br \/>\n<br \/>Adam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>Why Bleichmar Fonti &amp; Auld LLP?<\/b><\/p>\n<p>\nBFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by <i>Chambers USA<\/i>, <i>The Legal 500<\/i>, and <i>ISS SCAS<\/i>, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the <i>National Law Journal<\/i>, \u201cLitigation Stars\u201d by <i>Benchmark Litigation<\/i>, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by <i>Lawdragon<\/i>, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by <i>Law360<\/i> and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n<p>\nFor more information about BFA and its attorneys, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com&amp;index=6&amp;md5=14f33fcaa2cf976a341fedb7a15b7574\">https:\/\/www.bfalaw.com<\/a>.<\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54552257&amp;newsitemid=20260611491638&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=7&amp;md5=2dce7019bfe71395895c3d0b3ea0632c\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><\/p>\n<p><i>Attorney advertising. Past results do not guarantee future outcomes.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260611491638\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260611491638\/en\/<\/a><\/span><\/p>\n<p class=\"bwalignl\">\nAdam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>KEYWORDS:<\/b> United States North America New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260611491638\/en\/2829789\/3\/BFA_Law_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company\u2019s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-971424","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company\u2019s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information &hellip; Continue reading &quot;$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-11T17:36:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law\",\"datePublished\":\"2026-06-11T17:36:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/\"},\"wordCount\":853,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/\",\"name\":\"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-11T17:36:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/","og_locale":"en_US","og_type":"article","og_title":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk","og_description":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company\u2019s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information &hellip; Continue reading \"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-11T17:36:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law","datePublished":"2026-06-11T17:36:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/"},"wordCount":853,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/","name":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-11T17:36:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260611491638r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-breaking-news-adma-biologics-sued-for-securities-fraud-after-channel-stuffing-claims-lead-to-16-stock-drop-investors-notified-to-contact-bfa-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop \u2013 Investors Notified to Contact BFA Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=971424"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971424\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=971424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=971424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=971424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}